Ledger.Open graph →
SEC Form D · filed September 4, 2024

Superluminal Medicines, Inc

Offering
$120.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Diamantis Xylas · WALTHAM, MADirectorDylan Morris · San Fransicso, CADirectorCatherine Riesen · Morrisville, NCExecCony D'Cruz · BOSTON, MAExec · Director · PromoterAndrew Levin · BOSTON, MADirectorDiamantis Xylas · WALTHAM, MADirectorDylan Morris · Palo Alto, CADirectorCatherine Riesen · Morrisville, NCExecCony D'Cruz · BOSTON, MAExec · Director · PromoterAndrew Levin · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗